http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3560504-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6a6487902840957ea22664781405d8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
filingDate 1968-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1971-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243aaa2493903bc621c5df5ba700fb6c
publicationDate 1971-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3560504-A
titleOfInvention Virostatically effective substituted 3-alkenyl-5-ethyl uracil compounds
abstract HIGHLY EFFECTIVE VIROSTATIC AGENTS ARE SUBSTITUTED 5-ETHYL URACIL COMPOUNDS WHICH HAVE ALKENYL WITH 3 TO 6 CARBON ATOMS IN 3-POSITION AND MAY BE SUBSTITUTED IN 1POSITION BY ALKYL WITH 1 TO 4 CARBON ATOMS, CYCLOALKYL, ARYL, OR ARALKYL AND IN 4-POSITION BY HALOGEN. EXAMPLES OF SUCH COMPOUNDS ARE 1,5-DIETHYL-3-ALLYL-4-CHLORO URACIL, 1-METHYL-3-ALLYL OR CROTYL-4-CHLORO-5-ETHYL URACILS, 1METHYL OR ETHYL-3-ALLYL OR CROTYL-5-ETHYL URACILS. THEY ARE PREFERABLY OBTAINED BY ALKENYLATION IN 3-POSITION OF THE CORRESPONDING 5-ETHYL URACIL COMPOUNDS WHICH HAVE IN 3-POSITION HYDROGEN. THEY ARE PREFERABLY TOPICALLY APPLIED TO THE VIRUS-AFFECTED AREAS OF THE BODY IN THE FORM OF SOLUTIONS, OINTMENTS, POWDERS, SPRAYS, OR THE LIKE WHICH CONTAIN BETWEEN ABOUT 0.5% AND ABOUT 50% THEREOF.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5914399-A
priorityDate 1968-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415750940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420166489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415806325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354357
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421328696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154372150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54365309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73267
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421110303
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420173994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432481572

Total number of triples: 39.